Nursing care
Varenicline: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
Varenicline is a partial nicotinic agonist used for smoking cessation, started one week before the target quit date to build a steady blood level. Nausea and vivid dreams are expected and usually settle. Any new or worsening depressed mood, agitation, or thoughts of self-harm is not tolerated — stop the drug and escalate immediately.
Mechanism, simply
Varenicline binds the alpha-4 beta-2 nicotinic receptor as a partial agonist. It stimulates the receptor enough to blunt withdrawal and craving, but it also blocks nicotine from binding fully — so if the patient does smoke during treatment, the cigarette delivers less reward. That dual action is why it works better than simply removing nicotine.
It is not a nicotine replacement. There is no nicotine in the tablet, so it will not show up as nicotine on any screen, and it will not cause the tachycardia or hypertension you'd watch for with patches or gum. The relevant risks with varenicline sit in the CNS, not the cardiovascular system, and that is where your assessment should be weighted.
Indications you will see on the ward
Varenicline is prescribed for smoking cessation in adults, almost always as an outpatient or discharge-planning intervention rather than something started acutely on an inpatient unit. You'll see it initiated before a scheduled quit date, or added to a discharge plan after an MI, COPD exacerbation, or surgery where the admission itself becomes the motivation to quit.
The standard approach is to start it one week before the quit date. This lead time lets the drug reach a steady level so cravings are already blunted when the patient stops smoking, rather than asking them to quit cold and then wait for the medication to catch up. A shorter start-to-quit window is used in some regimens, but the one-week lead-in is the pattern most NCLEX items and most prescribing guides assume.
Assessment before administration
Before the first dose, establish a psychiatric baseline: mood, history of depression, anxiety, or prior suicidal ideation, and current mental state. This isn't a formality — it's the reference point you'll need later if mood changes during treatment, and it determines whether closer monitoring or a different cessation strategy is warranted.
Check renal function, since varenicline is renally cleared and the dose is reduced in significant renal impairment. Confirm the patient's smoking history and quit date, and screen for other CNS-active medications or alcohol use, since intoxication with alcohol has been associated with unusual behaviour in some patients taking varenicline.
Toxicity and the antidote
There is no specific antidote for varenicline. Overdose is managed supportively — monitor vital signs and mental status, and treat symptoms as they arise, since there is no reversal agent to give and no antagonist to call for.
This is a point worth holding onto for exam purposes: not every drug has a rescue agent, and varenicline is one of the ones that doesn't. What you do have is prevention through screening and early recognition through mood monitoring, which is why the assessment and teaching pieces of this drug carry more weight than they do for something like an opioid or a benzodiazepine.
Interactions that matter
Varenicline has relatively few pharmacokinetic drug interactions because it is not significantly metabolised by the liver and is largely excreted unchanged by the kidneys. That simplicity is part of why it's a first-line agent — it doesn't compete for the same enzyme pathways as many other medications.
The interaction that matters clinically is behavioural, not chemical: alcohol. Reduced alcohol tolerance and, rarely, unusual or aggressive behaviour have been reported when patients drink while taking varenicline. Advise patients to limit alcohol until they know how the combination affects them, and ask about alcohol use at every follow-up, not just at the start.
What the patient must be told
Tell the patient to start the tablet one week before their planned quit date and to keep taking it even if they slip and smoke — a lapse is not a reason to stop the medication. Vivid or unusual dreams and mild nausea are common and expected; taking the dose with food and a full glass of water reduces the nausea.
The instruction that overrides everything else: any new or worsening depressed mood, anxiety, agitation, hostility, or thoughts of self-harm means stop the medication and contact the prescriber or seek care immediately. Make sure a family member or support person also knows this sign, because the patient experiencing a mood change is not always the person best placed to notice it.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
When should varenicline be started relative to the quit date?
One week before the target quit date. This lets the drug reach a steady blood level so cravings are already reduced by the time the patient actually stops smoking.
Are vivid dreams on varenicline a reason to stop the drug?
No. Vivid or unusual dreams are a common, expected effect and don't on their own require stopping treatment. Reassure the patient and continue monitoring, reserving discontinuation for mood or behavioural changes.
What is the antidote for varenicline overdose?
There isn't one. Overdose is managed with supportive care and close monitoring of vital signs and mental status rather than a specific reversal agent.
Can a patient keep taking varenicline if they smoke a cigarette during treatment?
Yes. An occasional lapse is not a reason to discontinue the medication, since varenicline still blunts the reward from that cigarette. Encourage the patient to keep to the plan and return to full abstinence rather than stopping the drug out of guilt.
What single finding should make a nurse stop varenicline immediately?
Any new or worsening depressed mood, agitation, or thoughts of self-harm. This overrides everything else on the assessment and requires immediate escalation, not a wait-and-see approach.
More on pharmacology
Guides on this